Product image 1Boost
Product image 2Boost
Product image 3Boost
Product image 4Boost
Product image 5Boost

Regular price £24.99



BRAINXP Boost is a natural food supplement developed by our scientists to help you feel more energetic, replace sugary snacks and drinks, and reduce cravings.

BRAINXP Boost contains two popular medium-chain triglycerides (MCTs) found in coconut and palm oils: caprylic acid (C8) and capric acid (C10). Your body easily converts these natural MCT oils into ketones which boost energy levels, but unlike sugar, they don't get stored as body fat.  


Caprylic acid (C8)
Capric acid (C10)
(View scientific evidence datasheet)

  • Improve mental and physical energy levels
  • Suppress appetite
  • Improve athletic performance
  • Anti-microbial and anti-inflammatory properties



We manufacture BRAINXP Boost in the USA in FDA registered & inspected facility. 


Take four capsules daily, preferably with meals or as directed by a healthcare professional.


Nutritional Information
Serving Size 4 Liquid Capsules
Servings Per Container 30


Active Ingredient Per Serving
Medium Chain Triglycerides (MCTs) Typically Providing: 
3000 mg
Caprylic Acid 
1652 mg
Capric Acid 
1052 mg


Other Ingredients

Palm oil, gelatin (bovine) and vitamin E (d-alpha tocopheryl acetate).


Scientific Citations
  1. St-Onge MP, Bourque C, Jones PJ, Ross R, Parsons WE. Medium- versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int J Obes Relat Metab Disord. 2003 Jan;27(1):95-102.
  2. Tsuji H, Kasai M, Takeuchi H, Nakamura M, Okazaki M, Kondo K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J Nutr. 2001 Nov;131(11):2853-9.
  3. Koji Nagao, Teruyoshi Yanagita. Medium-chain fatty acids: Functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacological Research Volume 61, Issue 3, March 2010, Pages 208-212. 
  4. James E. Galvin. Optimizing diagnosis and management in mild-to-moderate Alzheimer's Disease. Neurodegener Dis Manag. Author manuscript; available in PMC 2012 Sep 10.
  5. Charles E.Isaacs, Richard E.Litov, Halldor Thormar. Antimicrobial activity of lipids added to human milk, infant formula, and bovine milk. The Journal of Nutritional Biochemistry Volume 6, Issue 7, July 1995, Pages 362-366.
  6. Marounek M, Skrivanova E, Rada V, 2003. Susceptibility of Escherichia coli to C2-C18 fatty acids. Folia Microbiol. 48:731-5.  Skrivanova V, Marounek M, 2002. Acta Vet. 71:435-9.
  7. Hanczakowska E, Szewcyk A, Okon K, 2011. Effects of dietary caprylic and capric acids on piglet performance and mucosal epithetlium structure of the ileum. J Anim & Feed Sci 20:556-65.
  8. Jeukendrup A, Saris W, Schrauwen P, Brouns F, Wagenmakers A (1995) Metabolic availability of medium-chain triglycerides coingested with carbohydrates during prolonged exercise. J Appl Physiol 79(3):756-62.
  9. Berning J (1996) The role of medium-chain triglycerides in exercise. Int J Sport Nutr 6(20):121-33.
  10. Gudmundur Bergsson, Jóhann Arnfinnsson, Ólafur Steingrímsson, and Halldor Thormar. In Vitro Killing of Candida albicans by Fatty Acids and Monoglycerides. Antimicrob Agents Chemother. 2001 Nov; 45(11): 3209–3212.
  11. Jon J. Kabara, Dennis M. Swieczkowski, Anthony J. Conley, and Joseph P. Truant. Fatty Acids and Derivatives as Antimicrobial Agents. Antimicrob Agents Chemother. 1972 Jul; 2(1): 23–28. 
  12. Gibson AA, Seimon RV, Lee CM, Ayre J, Franklin J, Markovic TP, Caterson ID, Sainsbury A. Do ketogenic diets really suppress appetite? A systematic review and meta-analysis. Obes Rev. 2015 Jan;16(1):64-76. doi: 10.1111/obr.12230. Epub 2014 Nov 17.
  13. P Sumithran, L A Prendergast, E Delbridge, K Purcell, A Shulkes, A Kriketos & J Proietto. Ketosis and appetite-mediating nutrients and hormones after weight loss. European Journal of Clinical Nutrition volume 67, pages 759–764 (2013). 
  14. Chearskul S, Delbridge E, Shulkes A, Proietto J, Kriketos A. Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations. Am J Clin Nutr. 2008 May;87(5):1238-46.
  15. Dulloo AG, Fathi M, Mensi N, Girardier L. Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: a dose-response study in a human respiratory chamber. Eur J Clin Nutr. 1996 Mar;50(3):152-8.
  16. Takeuchi H, Sekine S, Kojima K, Aoyama T. The application of medium-chain fatty acids: edible oil with a suppressing effect on body fat accumulation. Asia Pac J Clin Nutr. 2008;17 Suppl 1:320-3.
  17. St-Onge MP, Jones PJ. Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord. 2003 Dec;27(12):1565-71.
  18. Marie-Pierre St-Onge, Peter J. H. Jones. Physiological Effects of Medium-Chain Triglycerides: Potential Agents in the Prevention of Obesity. The Journal of Nutrition, Volume 132, Issue 3, 1 March 2002, Pages 329–332. 
  19. Baba N, Bracco EF, Hashim SA. Enhanced thermogenesis and diminished deposition of fat in response to overfeeding with diet containing medium chain triglyceride. Am J Clin Nutr. 1982 Apr;35(4):678-82.
  20. Coleman H, Quinn P, Clegg ME. Medium-chain triglycerides and conjugated linoleic acids in beverage form increase satiety and reduce food intake in humans. Nutr Res. 2016 Jun;36(6):526-33. doi: 10.1016/j.nutres.2016.01.004. Epub 2016 Jan 23.
  21. St-Onge MP, Jones PJ. Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int J Obes Relat Metab Disord. 2003 Dec;27(12):1565-71.
  22. Cunnane SC, Courchesne-Loyer A, St-Pierre V, Vandenberghe C, Pierotti T, Fortier M, Croteau E, Castellano CA. Can ketones compensate for deteriorating brain glucose uptake during aging? Implications for the risk and treatment of Alzheimer's disease. Ann N Y Acad Sci. 2016 Mar;1367(1):12-20. doi: 10.1111/nyas.12999. Epub 2016 Jan 14.
  23. Sharma A, Bemis M, Desilets AR. Role of Medium Chain Triglycerides (Axona®) in the Treatment of Mild to Moderate Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2014 Aug;29(5):409-14. doi: 10.1177/1533317513518650. Epub 2014 Jan 9.
  24. Mary T. Newport, Theodore B. VanItallie, Yoshihiro Kashiwaya, Michael Todd King, and Richard L. Veechd. A new way to produce hyperketonemia: use of ketone ester in a case of Alzheimer’s. Alzheimers Dement. 2015 Jan; 11(1): 99–103.
  25. Naohisa Nosaka, Yoshie Suzuki, Akira Nagatoishi, Michio Kasai, Jian Wu, Motoko Taguchi. Effect of Ingestion of Medium-Chain Triacylglycerols on Moderate- and High-Intensity Exercise in Recreational Athletes. Journal of Nutritional Science and Vitaminology. 2009 Volume 55 Issue 2 Pages 120-125. 

For any questions about the product please contact us: 

  • Email:
  • WhatsApp: (+44) 075 26 333 823 
  • Or use 'Message Us' button on our website (desktop computers only)

We will be happy to help!


Your feedback is crucial for product development and we take it very seriously. 
We aim to constantly improve our product formulas in line with the scientific research and your feedback.

Please leave a review below or email and receive a  special discount code for BRAINXP products! 





Open tab

Customer Reviews

Based on 4 reviews Write a review
Close (esc)



Age verification

By clicking enter you are verifying that you are old enough to consume alcohol.


Shopping Cart

Your cart is currently empty.
Shop now